Newstral
Article
Shropshire Star on 2024-04-25 14:40
Cancer drugs help drive AstraZeneca sales sharply higher
Related news
- Cancer drugs help drive AstraZeneca sales sharply higherexpressandstar.com
- AstraZeneca profits soar on cancer drugs, Alexion buytimesofmalta.com
- AstraZeneca earnings up 55% driven by sales of cancer drugsSeattle Times
- TAstraZeneca signs billion-dollar deal with Japanese pharmaceutical giant to develop and sell cancer drugsthisismoney.co.uk
- AstraZeneca PLC: Cancer drugs help AstraZeneca beat forecastsFinancial Times
- AstraZeneca says 4th-Q earns triple on cancer drugs salesSeattle Times
- FAstraZeneca to pay $600m for Actavis drugsft.com
- AstraZeneca boosted by strong drugs s...Shropshire Star
- Encouraging phase III trial results for AstraZeneca for lung cancer and prostate cancer drugscambridgeindependent.co.uk
- TAstraZeneca has two of its cancer drugs approved for use in the EUthisismoney.co.uk
- IAstraZeneca stock price falls sharply on a $39 billion bill to buy Alexioninvezz.com
- Cancer treatments offset tumbling Covid drug sales at AstraZenecaShropshire Star
- AShares in AstraZeneca dive as key cancer drug trial failsapnewsarchive.com
- AstraZeneca sales hit by competition from rival cholesterol drugsShropshire Star
- AstraZeneca revenue down as key drugs lose patent protectionseattletimes.com
- BAstraZeneca Climbs as New Cancer Drug Sales Soarbarrons.com